Integrative Cessation Program for co-smokers of cigarettes and cannabis

Completed

• Conditions: icotine dependence and cannabis misuse/abuse; Mental and Behavioural Disorders; Mental and behavioural disorders due to use of cannabinoids

• Registration Number: ISRCTN15248397
• Lead Sponsor: Swiss Tobacco Prevention Fund (Switzerland)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-03-12
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

1. Minimal age 18, either sex
2. Smoking at least five cigarettes per day in the past 30 days prior to study entry
3. At least once a week cannabis use in the past 30 days prior to study entry

Exclusion Criteria

1. Current serious psychiatric illness or history of psychosis, schizophrenia, bipolar type I disorder or significant current suicidal or homicidal thoughts
2. Use of bupropion or nicotine replacement therapy (NRT) or other smoking cessation treatment at study entry
3. Current behavioral treatments for cessation of marijuana or tobacco smoking
4. Inability to read or write in German

Study & Design

• Study Type: Interventional
• Study Design: Not specified